Previous 10 | Next 10 |
SAN DIEGO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other lif...
Completed 12 Investments in New and Existing Portfolio Companies Representing $327 Million in New Commitments and $232.6 Million in Funded Loans Total Loan Commitments and Funded Investments Grew to $2.3 Billion and $1.8 Billion Since Inception WOODSIDE, Calif., Jan. 10, 2023 (GLOBE N...
Penny Stocks To Buy According To Analysts As the stock market continues to become more and more unpredictable, it’s increasingly important for traders to use every available tool. Whether you’re trading penny stocks or higher-priced shares, one of those tools is analyst insi...
TRACON Pharmaceuticals ( NASDAQ: TCON ) announced entry into an up to $30M non-recourse financing agreement. $3.5M will be funded before December 31, 2022. The additional $26.5M, or a lesser amount based on the amount awarded, will be available subject to the award exceeding a thr...
SAN DIEGO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life scie...
Tracon Pharma ( NASDAQ: TCON ) is trading ~17% higher premarket after the company announced positive data from a phase 2 trial testing its drug, Envafolimab, as monotherapy and in combination with Yervoy, to treat solid tumors. The Independent Data Monitoring Co...
Objective Response Rate (ORR) by Central Review Achieved in Each Cohort at Interim Efficacy Analysis that Exceeded the Futility Threshold Enrollment Continues Ahead of Schedule; Next Interim Analysis Expected in mid-2023 with Full Accrual Now Expected Before the End of 2023 Arbi...
SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with oth...
Tracon press release ( NASDAQ: TCON ): Q3 GAAP EPS of -$0.30 beats by $0.02 . Cash and cash equivalents were $17.0M at September 30, 2022, compared to $24.1M at December 31, 2021, and is expected to fund the company into mid-2023. For further details see: Tra...
TRACON Pharmaceuticals, Inc. (TCON) Q3 2022 Earnings Conference Call November 14, 2022, 16:30 ET Company Participants Charles Theuer - CEO, President & Director Scott Brown - CFO Conference Call Participants Joel Beatty - Robert W. Baird & Co. ...
News, Short Squeeze, Breakout and More Instantly...
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
OTCMKTS Market:
TRACON Pharmaceuticals Inc. Website:
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was made at a special meeting of the board of directors. The board of directors appointed Craig R....
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...